wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33699808-1B29D074-A87D-48ED-8023-68F7937BB1B2
Q33699808-1B29D074-A87D-48ED-8023-68F7937BB1B2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33699808-1B29D074-A87D-48ED-8023-68F7937BB1B2
Combined ALK and MDM2 inhibition increases antitumor activity and overcomes resistance in human ALK mutant neuroblastoma cell lines and xenograft models.
P2860
Q33699808-1B29D074-A87D-48ED-8023-68F7937BB1B2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33699808-1B29D074-A87D-48ED-8023-68F7937BB1B2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
babee370985f519c5f188a9111769efdcd1ff85a
P2860
Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia.